CN104407077A - 一种mes,nhs残留的hplc检测方法 - Google Patents
一种mes,nhs残留的hplc检测方法 Download PDFInfo
- Publication number
- CN104407077A CN104407077A CN201410839225.6A CN201410839225A CN104407077A CN 104407077 A CN104407077 A CN 104407077A CN 201410839225 A CN201410839225 A CN 201410839225A CN 104407077 A CN104407077 A CN 104407077A
- Authority
- CN
- China
- Prior art keywords
- mes
- nhs
- detection method
- hplc detection
- residual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 36
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 45
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000008363 phosphate buffer Substances 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 10
- 239000012086 standard solution Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 35
- 239000012074 organic phase Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 239000008346 aqueous phase Substances 0.000 description 15
- 238000004132 cross linking Methods 0.000 description 15
- 238000000926 separation method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 9
- 230000014759 maintenance of location Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001718 carbodiimides Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000008213 purified water Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Description
有机相 | MES保留时间(min) | NHS保留时间 |
甲醇 | 2.956 | 4.018 |
乙腈 | 2.813 | 3.962 |
流动相组别 | 流动相pH | 配制方法(磷酸盐缓冲液) |
1 | 6.5 | 称取磷酸二氢钾2.8g,加0.1mol/L的氢氧化钠溶液152mL,再稀释至1000mL,微孔滤膜过滤超声待用 |
2 | 5.8 | 取磷酸二氢钾8.34g,和磷酸氢二钾0.87g,定容至1000mL,微孔滤膜过滤超声待用 |
3 | 5.0 | 取0.2mol/L磷酸二氢钠溶液一定量,用氢氧化钠试液调节至pH=5.0,微孔滤膜过滤超声待用 |
峰号 | 保留时间 | 面积 | 高度 |
1 | 2.952 | 1573010 | 252662 |
2 | 4.010 | 118625 | 19121 |
总计 | 1691635 | 271783 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410839225.6A CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410839225.6A CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104407077A true CN104407077A (zh) | 2015-03-11 |
CN104407077B CN104407077B (zh) | 2016-02-24 |
Family
ID=52644724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410839225.6A Active CN104407077B (zh) | 2014-12-30 | 2014-12-30 | 一种mes,nhs残留的hplc检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104407077B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104833753A (zh) * | 2015-05-12 | 2015-08-12 | 苏州景卓生物技术有限公司 | Edc残留的hplc-elsd检测方法 |
CN108226363A (zh) * | 2017-12-04 | 2018-06-29 | 赵欣雨 | 一种利用hplc检测尿激酶分子组分比的方法 |
CN108982694A (zh) * | 2018-07-27 | 2018-12-11 | 西藏多瑞医药有限公司 | 一种n-溴代丁二酰亚胺有关物质的检测方法 |
CN109917121A (zh) * | 2019-03-01 | 2019-06-21 | 洛阳恒恩生物科技有限公司 | 胱抑素c测定试剂盒及其制备方法 |
CN109975440A (zh) * | 2017-12-28 | 2019-07-05 | 江苏众红生物工程创药研究院有限公司 | 一种nhs残留的检测方法 |
CN114965761A (zh) * | 2022-05-17 | 2022-08-30 | 深圳赛保尔生物药业有限公司 | 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法 |
CN117491522A (zh) * | 2023-11-03 | 2024-02-02 | 江苏创健医疗科技股份有限公司 | 一种n-羟基琥珀酰亚胺残留量的检测方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421609A (zh) * | 2006-01-24 | 2009-04-29 | 阿普里拉股份有限公司 | 与分析物测定相关的方法、混合物、试剂盒和组合物 |
WO2009064321A2 (en) * | 2007-11-14 | 2009-05-22 | Ateris Technologies. Llc | Biomarker detection |
-
2014
- 2014-12-30 CN CN201410839225.6A patent/CN104407077B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101421609A (zh) * | 2006-01-24 | 2009-04-29 | 阿普里拉股份有限公司 | 与分析物测定相关的方法、混合物、试剂盒和组合物 |
WO2009064321A2 (en) * | 2007-11-14 | 2009-05-22 | Ateris Technologies. Llc | Biomarker detection |
Non-Patent Citations (4)
Title |
---|
HUNGCHI NIAN等: "Electrochemical immunoassay of cotinine in serum based on nanoparticle probe and immunochromatographic strip", 《ANALYTICA CHIMICA ACTA》, vol. 713, 31 December 2012 (2012-12-31), pages 50 - 55, XP028351987, DOI: doi:10.1016/j.aca.2011.11.028 * |
JEFF S. XU等: "Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging", 《BIOMATERIALS》, vol. 31, 31 December 2010 (2010-12-31), pages 1716 - 1722, XP026827530 * |
张瑜等: "靶向血栓 MR 分子探针的构建及初步鉴定", 《临床放射学杂志》, vol. 31, no. 8, 31 December 2012 (2012-12-31), pages 1178 - 1182 * |
陈玮等: "用液相芯片技术定量测定人血清 CEA、AFP 和 HBsAg", 《中山大学学报(医学科学版)》, vol. 28, no. 1, 31 January 2007 (2007-01-31) * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104833753A (zh) * | 2015-05-12 | 2015-08-12 | 苏州景卓生物技术有限公司 | Edc残留的hplc-elsd检测方法 |
CN108226363A (zh) * | 2017-12-04 | 2018-06-29 | 赵欣雨 | 一种利用hplc检测尿激酶分子组分比的方法 |
CN109975440A (zh) * | 2017-12-28 | 2019-07-05 | 江苏众红生物工程创药研究院有限公司 | 一种nhs残留的检测方法 |
CN108982694A (zh) * | 2018-07-27 | 2018-12-11 | 西藏多瑞医药有限公司 | 一种n-溴代丁二酰亚胺有关物质的检测方法 |
CN109917121A (zh) * | 2019-03-01 | 2019-06-21 | 洛阳恒恩生物科技有限公司 | 胱抑素c测定试剂盒及其制备方法 |
CN114965761A (zh) * | 2022-05-17 | 2022-08-30 | 深圳赛保尔生物药业有限公司 | 聚乙二醇化蛋白药物中n-羟基琥珀酰亚胺的检测方法 |
CN117491522A (zh) * | 2023-11-03 | 2024-02-02 | 江苏创健医疗科技股份有限公司 | 一种n-羟基琥珀酰亚胺残留量的检测方法 |
CN117491522B (zh) * | 2023-11-03 | 2024-05-07 | 江苏创健医疗科技股份有限公司 | 一种n-羟基琥珀酰亚胺残留量的检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104407077B (zh) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104407077B (zh) | 一种mes,nhs残留的hplc检测方法 | |
Kataoka | New trends in sample preparation for clinical and pharmaceutical analysis | |
Edlund | Determination of opiates in biological samples by glass capillary gas chromatography with electron-capture detection | |
CN105158358A (zh) | 同时检测中成药和保健品中非法添加的42种化学药品的方法 | |
V. Soares Maciel et al. | Recent trends in sorption‐based sample preparation and liquid chromatography techniques for food analysis | |
CN103454360A (zh) | 超滤联合uplc-ms/ms法测定人血浆中游离多西他赛浓度 | |
CN105136951A (zh) | 一种茶叶多糖单糖组成的快速定量方法 | |
CN112782311B (zh) | 一种富马酸丙酚替诺福韦中l-丙氨酸异丙酯的hplc测定方法 | |
CN103645257A (zh) | 木瓜饮片的检测方法 | |
CN101738444A (zh) | 三聚氰胺的检测方法 | |
CN106033079B (zh) | 甲磺酸达比加群酯起始物料f中有关物质咪唑的检测方法 | |
CN110967431B (zh) | 一种高效液相色谱法测定卡托普利片中d-卡托普利和卡托普利有关物质8的方法 | |
CN102495145A (zh) | 检测塑料产品中双酚a的方法 | |
CN104634911B (zh) | 一种喘可治注射液4种黄酮类有效成分检测方法 | |
CN103487545A (zh) | 卡巴胆碱及其杂质含量的液相色谱检测方法 | |
CN114669280B (zh) | 磺胺类药物残留的净化填料及前处理方法 | |
El-Attug et al. | Method development and validation for trifluoroacetic acid determination by capillary electrophoresis in combination with capacitively coupled contactless conductivity detection (CE-C4D) | |
CN103884789A (zh) | 一种快速测定灵芝产品中多糖肽的方法 | |
CN104007185A (zh) | 一种检测扎那米韦及含扎那米韦制剂中杂质的hplc测定方法 | |
CN111044636A (zh) | 米卡芬净含量的分析方法 | |
CN106645474A (zh) | 丹绿补肾胶囊中次野鸢尾黄素和胡椒碱的含量测定方法 | |
CN202947998U (zh) | 色谱仪 | |
CN107655986B (zh) | 一种维帕他韦有关物质的检测方法 | |
CN102109499A (zh) | 用气相色谱同时检测药物中丙酮和乙酸乙酯残留的方法 | |
Dongare et al. | A review of chromatograph: Principal, classification, application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Zhongke Inventor after: Sun Liman Inventor after: Yang Anshun Inventor after: Jiang Xiaolong Inventor after: Gong Yanming Inventor after: Chen Weiying Inventor after: Ding Xiang Inventor after: Li Juan Inventor after: Li Haoyu Inventor after: Zhang Zhaoli Inventor after: Yang Xiufu Inventor after: Peng Hongwei Inventor before: Yang Zhongke Inventor before: Peng Hongwei Inventor before: Gong Yanming Inventor before: Chen Weiying Inventor before: Ding Xiang Inventor before: Li Juan Inventor before: Li Haoyu Inventor before: Zhang Zhaoli Inventor before: Yang Anshun Inventor before: Jiang Xiaolong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG ZHONGKE GONG YANMING CHEN WEIYING DING XIANG LI JUAN LI HAOYU ZHANG ZHAOLI YANG ANSHUN JIANG XIAOLONG PENG HONGWEI TO: YANG ZHONGKE GONG YANMING CHEN WEIYING DING XIANG LI JUAN LI HAOYU ZHANG ZHAOLI YANG XIUFU PENG HONGWEI SUN LIMAN YANG ANSHUN JIANG XIAOLONG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161230 Address after: 215400 Taicang province Jiangsu city Shaxi town Guizhuang District Road No. 4 Building Xiangtang Zhenhui property Patentee after: Suzhou Jing Zhuo Bioisystech Co., Ltd Address before: Suzhou City, Jiangsu Province, Suzhou Industrial Park 213111 Xinghu Street No. 218 BioBAY A5 building 101-105 unit Patentee before: Suzhou Dapu Biological Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190821 Address after: 310013 No. 206 Zhenzhong Road, Sandun Town, Xihu District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Jing Jia Medical Technology Co., Ltd. Address before: 215400 Taicang province Jiangsu city Shaxi town Guizhuang District Road No. 4 Building Xiangtang Zhenhui property Patentee before: Suzhou Jing Zhuo Bioisystech Co., Ltd |